IT
Healthcare & Life Sciences
Immunitas Therapeutics
United States
Immunitas Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Immunitas Therapeutics
Immunitas Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops targeted therapeutics for complex diseases by applying novel single-cell analysis methods to identify and prioritize drug targets, focusing on oncology and immunology in clinical stages.
Explore Immunitas Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.